Isolated polycystic liver disease
- PMID: 20219621
- PMCID: PMC2837599
- DOI: 10.1053/j.ackd.2009.12.005
Isolated polycystic liver disease
Abstract
Isolated polycystic liver disease (PCLD) is an autosomal dominant disease with genetic and clinical heterogeneity. Apart from liver cysts, it exhibits few extrahepatic manifestations, and the majority of patients with this condition are asymptomatic or subclinical. However, a small fraction of these patients develop acute liver cyst-related complications and/or massive cystic liver enlargement, causing morbidity and mortality. Currently, the management for symptomatic PCLD is centered on palliating symptoms and treating complications.
2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.
Figures
References
-
- Melnick PJ. Polycystic liver; analysis of seventy cases. AMA Arch Pathol. 1955;59(2):162–172. - PubMed
-
- Moschcowitz E. Non-parasitic cysts (congenital) of the liver, with a study of aberrant bile ducts. The American Journal of the Medical Sciences. 1906;131(4):674–699.
-
- Feldman M. Polycystic disease of the liver. Am J Gastroenterol. 1958;29(1):83–86. - PubMed
-
- Berrebi G, Erickson RP, Marks BW. Autosomal dominant polycystic liver disease: a second family. Clin Genet. 1982;21(5):342–347. - PubMed
-
- Tahvanainen P, Tahvanainen E, Reijonen H, Halme L, Kaariainen H, Hockerstedt K. Polycystic liver disease is genetically heterogeneous: clinical and linkage studies in eight Finnish families. J Hepatol. 2003;38(1):39–43. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources